Updated Oct 27, 2026 · 09:24 UTC
PFEPfizer Inc
Health Care · United States · XNYS · pharmaceutical preparations
$29.80−0.80%last session · market early-hours
Market cap
$169.82b
real-world
Tokenized
$4.2m
0.002% of the asset
Avg token price
$31.19
+4.69% vs real
Spot volume, 24h
$2k
4 venues
Derivatives, 24h
—
Perp open interest
—
In DeFi
—
PFE · Price
Token Real
EarningsNasdaq’s earnings calendar
Next earnings
Nov 3
before the open · Sep 2026 quarter · EPS forecast $0.72 (5 analysts)
Last earnings, Aug 4
$0.77 EPS
+13.2% vs $0.68 forecast · Jun 2026 quarter
Real marketPfizer Inc.
Last close
$30.03
Oct 23
Traded on Oct 23
$885.4m
Price now
$29.80
market early-hours
Where it trades24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · $2k · 4 venues
Ondo Stocks1 pair$853
Kraken1 pair$494
Deluthium1 pair$348Derivatives · — · 0 venues
None yet
In DeFiPools and lending markets that hold these tokens
None found
Onchain versions5 tokens from 4 issuers
PFEonOndo Assets$31.62$3.8m
PFEXBacked Assets$29.68$354k
PFEcCoinbase$143.15$1k
PFE.DDinari Assets——
WPFEXBacked Assets——HoldersAddresses holding its tokens on each chain counted, each token counted and added, issuers’ own addresses left out · the value is what they hold onchain
BNB Chain212 holders$97k
Solana202 holders$343k
Ethereum160 holders$3.8m
Base121 holders$1k
TON17 holders$15k
Ink13 holders$9k
Arbitrum— holders$0Business 12 months to Jun 2026 · SEC EDGAR
Results
Revenue
$63.70b
−0% YoY
Net income
$4.33b
7% margin · −60% YoY
EPS, diluted
$0.76
−60% YoY
Diluted shares
5.70b
−0% YoY
Cash and balance sheet
Free cash flow
$10.98b
17% of revenue · 6.5% yield
Net debt
$54.94b
$8.26b cash and securities, $63.19b debt
Quarterly
RevenueNet income
Valuation today’s market cap $169.82b · enterprise value $224.76b
P/E
39.2×
EV / sales
3.5×